Leuven Gynaecological Oncology Group
Shaping the future treatments for our patients
Here you can find our current clinical trials for vulvar and vaginal cancer and trophoblast disease
We're here to help with your therapy
LGOG, the Leuven Gynaecological Oncology Group, originated from the department of gynaecological oncology at the UZ Leuven.
Our department specialises in the diagnosis and treatment of gynaecological cancers. These include cancers of the ovaries, fallopian tubes, peritoneum, uterus, cervix and placenta.
Message board
Symposium Gynaecologic pelvine oncology: 'From evidence to reality'
On Wednesday November 25th, 2026 the first symposium of Gynaecologic Pelvine Oncology will take place. The goal of this symposium is to gather health care professionals to translate new insights in…
New Study Confirms Beneficial Effect of Relacorilant
An international phase III study conducted by Corcept demonstrates that the combination of relacorilant and nab-paclitaxel results in a statistically significant improvement in progression-free…
Pembrolizumab Improves Disease-Free Survival in dMMR Endometrial Carcinoma
A randomized double-blind phase III study conducted by Merck Sharp & Dohme demonstrates that adding pembrolizumab to first-line chemotherapy does not improve disease-free survival in the overall…

